Each of the serotypes of Haemophilus influenzae (types a to f) may colonize the respiratory tract of humans, but only type b strains commonly cause invasive systemic infections. To investigate the role of complement in immunity to encapsulated non-type b strains, rats were depleted of C3 with cobra venom factor and challenged with representative serotypes of H. influenzae (type a, b, c, or d) by different routes. After intravenous challenge, rats depleted of C3 had a greater incidence and magnitude of bacteremia with each of the serotypes when compared with normal controls. Intraperitoneal inoculation of type b organisms resulted in meningitis in normal and C3-depleted rats, but only C3-depleted, and not normal, rats developed meningitis after inoculation of serotype a, c, or d. In contrast to systemic inoculation, intranasal challenge with the different serotypes resulted in bloodstream invasion and meningitis only after challenge with type b organisms. These data suggest that complement plays a significant role in immunity to encapsulated, non-type b H. influenzae through its effect on bloodstream clearance.
colonize respiratory mucosa, only type b strains commonly cause systemic infections (3, 4, 9) . The basis for the unique proclivity of type b organisms to cause invasive disease is not known.
The complement system plays an important role in host defense against a variety of bacterial, fungal, and viral infections. Previous studies have shown that infant rats depleted of C3 by cobra venom factor (CoVF) are more susceptible to Hi type b bacteremia and meningitis than are control animals (2) . Infant rats offer a biologically relevant model of disease in humans since after intranasal (i.n.) challenge with various serotypes of Hi, induction of bacteremia and meningitis occurs only with strains of serotype b, but not with other encapsulated serotypes (7a). One possible basis for the relative pathogenicity of different Hi serotypes may be their differing interaction with the complement system. The following experiments were performed to determine whether C3 depletion in rats altered their susceptibility to infection with encapsulated Hi other than type b.
MATERIALS AND METHODS
Animals. The 90-day-old (average weight, 130 g) and 5-day-old newborn COBS/CD albino Sprague Dawley rats were purchased from Charles River Breeding Laboratories, Inc., Wilmington, Mass., and maintained as previously described (7).
CoVF. Purified CoVF obtained from Naja naja venom was purchased from Cordis Laboratories, Miami, Fla. The CoVF was reconstituted in sterile saline to a concentration of 100 U/ml and frozen at -70°C until use.
C3 depletion. The 90-day-old rats were injected intraperitoneally (i.p.) with either 125 U of CoVF per kg of body weight or an equal volume of sterile saline. The 5-day-old infant rats were injected i.p. with either 300 U of CoVF per kg of body weight or an equal volume of sterile saline. C3 determinations. Serum was obtained by serial tail bleeding from five rats at each time point, pooled, and stored at -70°C. C3 titers were deteminined simultaneously on all samples by the functional hemolytic assay of Shin and Mayer (10) .
Bacteria. The strains of encapsulated Hi types a (strain Morgan), b (strain Simpkin), c (ATCC strain 9007), and d (ATCC strain 9008) and unencapsulated Hi (strains S and U-1) have been previously described (7a), as have the methods of growth (7), quantitation (7), and i.p. (11) or i.n. (7a) inoculation.
All animals were inoculated with bacteria 3 h after treatment with either CoVF or sterile saline. Intravenous (i.v.) inoculation was performed in the 90-day-old rats via the lateral tail vein (7a). The 5-day-old newborn rats were inoculated by the i.p. or i.n. route.
Sampling of blood and CSF. Cerebrospinal fluid (CSF) was collected by a previously described method (7a). Blood cultures were performed in 90-day-old rats by obtaining blood by intracardiac puncture; both 0.1 ml of undiluted blood and 0.1 ml of a 1:100 dilution were plated. Blood cultures were performed in 5-dayold rats by tail vein puncture with 0.01 ml of undiluted blood plated as previously described (7a) .
Statistical analysis. Comparison of the incidence of bacteremia and meningitis was performed by the X2 test with Yates continuity correction, and the magnitude of bacteremia and the concentration of bacteria in CSF samples were compared by Student two-tailed t test (1).
RESULTS
Effect of CoVF on C3 titers. The serum C3 titer fell rapidly to less than 10%o of the control value in the 90-day-old weanling rats within 3 h after the CoVF administration and remained at this level for 5 days (Fig. 1) To study the effect of complement depletion on the development of meningitis, 5-day-old newborn rats were inoculated i.p. Figure 2 shows the incidence of bacteremia and meningitis and the magnitude of bacteremia in C3-depleted and control rats 24 h after inoculation. Depletion of C3 enhanced the occurrence of bacteremia due to type a, c, or d. Meningitis was not observed in control rats inoculated with encapsulated strains other than type b. In contrast, more than 50% of C3-depleted rats challenged with types a, c, and d had meningitis as evidenced by inflammatory cells, visible organisms upon a Gram stain, and positive cultures of 
DISCUSSION
Previous studies showed that complement is important in host defense against Hib in an experimental infection of rats (2) . The h, the frequency and magnitude of bacteremia were similar to those observed in rats inoculated with the type b strain. As anticipated from the above studies that used the i.v. challenge route, bacteremia was also substantially increased in complement-depleted rats inoculated i.p. However, these studies were principally devised to determine whether meningitis resulted. The occurrence of meningitis in complement-depleted rats challenged with the type a, c, and d serotypes was in marked contrast to the control animals challenged with these same serotypes. The fact that those complement-depleted animals who had a sustained high level bacteremia with the type a, c, or d organisms also had meningitis is consistent with previous data with type b strains where bacteremia of equal to, or greater than, 103 bacteria per ml was found to be necessary, but not sufficient, to result in meningeal invasion (6) . These data do not indicate whether complement depletion directly affected central nervous system invasion or whether the occurrence of meningitis was a function of decreased clearance of bacteria in the bloodstream. Our previous studies with another type b strain (2) strongly favored the latter possibility but do not necessarily pertain to other type b strains or to heterologous serotypes.
In contrast to the effect of complement depletion in rats inoculated systemically, no detectable effect was observed in cobra venom-treated rats after i.n. challenge. Thus, C3 depletion did not seem to be a determinant of bloodstream invasion from the nasopharynx. These findings were of particular interest vis-a-vis a previous study with a different type b strain (Eagan) where cobra venom treatment significantly enhanced invasiveness (2) . Thus, quantitative differences in the amount of capsule, as well as determinants of pathogenicity other than serotype, may be critical. Studies with both wild and isogenic or transformed strains are clearly indicated.
In summary, these studies extend our previous investigations to indicate an important role for complement in host defense against encapsulated Hi other than type b. The effect of complement depletion seemed to result from impaired intravascular clearance of bacteria rather than enhanced bloodstream invasion from the nasopharynx. Type b strains possess unique virulence characteristics both as regards naturally occurring invasive infection of humans and experimental infections of rats. Differences in the pathogenicity of encapsulated (type b and nontype b) Hi may be determined at least in part by differences in their interaction with the complement system which plays an important role in the host's defense against bacteremia and meningitis.
